KDM1A and estrogen-receptor negative breast cancer: The Eraser LSD1 (Lysine-specific histone demethylase 1) is highly expressed in estrogen-receptor negative breast cancer and predicts aggressive biology [71] and inhibition of LSD1 resulted in growth inhibition of breast cancer cells.